HIGHLIGHTS
- who: January and colleagues from the Abasyn University, Pakistan University of Bologna, Italy have published the research work: A novel risk model based on anoikis: Predicting prognosis and immune in ltration in cutaneous melanoma, in the Journal: (JOURNAL)
- what: During tumorigenesis, the isolated tumor cells bypass death signaling pathways and escape immune recognition, which is the main reason for the occurrence of anoikis resistance (Shi et_al, 2022). This research provides a framework regarding the co-administration of targeted therapy and immunotherapy in CM treatment that may also assist in the development of individualized treatment. In . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.